Abstract Type 1 diabetes is an autoimmune disorder characterized by a lack of insulin production by the beta cells of the pancreas. This lack of insulin causes a variety of systemic effects on whole-body metabolism. Poorly managed type 1 diabetes can lead to cardiovascular disease, diabetic neuropathy, and diabetic retinopathy. Increasingly, even well-managed type 1 diabetic patients show damage to peripheral organs related to complications from the disease. The central role of insulin in energy homeostasis also renders it an important signaling factor in the reproductive tract. type 1 diabetes has now been demonstrated to cause defects in sperm and testes. The aim of this review is to present the known effects of insulin's role in the function of the male reproductive tract. These effects might be mediated through hormonal alterations in the hypothalamic pituitary gonadal axis or through the direct interaction of insulin on the testes and sperm cells. Although fertility complications also occur in type 2 diabetic males, this review will focus on the defects specifically linked with the lack of insulin seen in type 1 diabetes.
Introduction
Type 1 diabetes is an autoimmune disorder characterized by a lack of insulin production by the beta cells of the pancreas (Yoon and Jun 2005) . This lack of insulin causes a variety of systemic effects on whole-body metabolism. Poorly managed type 1 diabetes can lead to cardiovascular disease, diabetic neuropathy, and diabetic retinopathy (Barber 2003; Said 2007; Sowers et al. 2001; Vinik et al. 1992) . Increasingly, even well-managed type 1 diabetic patients show damage to peripheral organs related to complications from the disease. The central role of insulin in energy homeostasis also renders it an important signaling factor in the reproductive tract. type 1 diabetes has recently been shown to cause defects in sperm and testes. The aim of this review is therefore to present the known role and effect of insulin on the male reproductive tract. Although fertility complications also occur in type 2 diabetic males, this review will focus on the defects specifically linked with the lack of insulin associated with type 1 diabetes.
The link between type 1 diabetes and fertility has long been established. Accounts dating as far back as the 11th century have described the disease as "a collapse of sexual functions", highlighting the importance of insulin in the reproductive system. Whereas our current understanding of the mechanism of this subfertility has greatly progressed since the 11th century, it remains unclear whether the damage to sperm is attributable to local effects from hyperglycemia or to alterations in hormone levels that disrupt the hypothalamic pituitary gonadal (HPG) axis.
Diabetes is associated with reduced sperm parameters in affected males. The recent discovery that both the testes and sperm themselves produce insulin brings a new perspective on the way that diabetes might contribute to subfertility. Indeed, insulin expression in the testes also seems to be affected by diabetes, with streptozocin-induced diabetic rats expressing less than half of the insulin protein compared with nondiabetic controls (Gómez et al. 2009 ). This suggests that insulin might have an important role in spermatogenesis. In addition to the testes, sperm cells have also been shown to contain both insulin mRNA and protein (Aquila et al. 2005) . These cells are activated by insulin to induce pAKT (serine/threonine protein kinase) phosphorylation, suggesting a functional role in insulin signaling. Additionally, these cells have been shown to secrete insulin in response to glucose administration. These contributions open a new avenue of research into the functions of insulin in the reproductive tract as the specific role of insulin in the process of spermatogenesis and sperm motility and/or capacitation has not been determined.
In a normally functioning HPG axis, the hypothalamus releases gonadotropin-releasing hormone (GnRH) pulses that stimulate the pituitary to secrete both luteinizing hormone (LH) and follicle-stimulating hormone (FSH; Fig. 1 ). LH and FSH act on the Sertoli cells and the Leydig cells, respectively, to stimulate the process of spermatogenesis. The onset of type 1 diabetes is known to disrupt the HPG axis, resulting in impaired spermatogenesis and subsequent subfertility.
Disruptions in any part of the HPG axis impair fertility. This review will focus on the manner in which these disruptions lead to infertility. Specifically, we will focus on the effects of type 1 diabetes on: (1) insulin and leptin levels, (2) GnRH pulses from the hypothalamus, (3) LH and FSH secretion from the pituitary, (4) testosterone secretion from the Leydig cells, and (5) sperm quality. Additionally, we will address the possibility of local insulin signaling within the testes and the way that type 1 diabetes might locally affect the gonads.
Insulin/leptin effects on the HPG axis
Insulin levels mediate the function of the HPG axis Serum insulin has long been known to affect the central nervous system, and these effects might mediate wholebody energy homeostasis, including the reproductive axis, through further signaling to the pituitary and, ultimately, the gonads. A study in 1977 by Porte et al. (2005) showed that peripheral insulin injection caused an increase in insulin levels in cerebral spinal fluids, suggesting that insulin could potentially be a signal to the brain regarding energy stores and promoting whole-body energy homeostasis. Thus, a lack of insulin would signal to the brain a lack of energy supply, and the central nervous system could potentially shut down extraneous energy-consuming processes such as reproductive function.
Indeed, insulin levels have dramatic effects on the regulation of the HPG axis. The effects of diabetes on the reproductive axis are mediated, at least in part, by signaling in the brain. Insulin mediates its effects through binding with the insulin receptor, resulting in a signaling cascade. Through interactions with the insulin receptor substrate proteins, notably IRS-2, insulin potentiates signaling through phosphatidyl inositol 3-kinase (PI3-kinase), which then activates AKT, an important mediator of energy signaling (Boura-Halfon and Zick 2009).
Insulin signaling in the brain can happen at multiple sites. Insulin receptor expression has been detected in the hypothalamus, the olfactory bulb, and the pituitary (Havrankova et al. 1981) . Additionally, insulin concentrations in the brain are markedly higher than plasma insulin levels, suggesting that insulin in the brain is not simply a reflection of serum levels, but that this signaling hormone has a crucial function in the central nervous system (Havrankova et al. 1978 ).
The precise impact that insulin in the brain has on changes in the reproductive axis is unknown. An experiment with a brain-specific insulin receptor knockout has revealed the connection between insulin signaling in the brain and fertility. The development of a neuron-specific insulin receptor knockout mouse (NIRKO) results in subfertile male mice. Male NIRKO mice display a significant reduction in fertility, with 46% of matings resulting in offspring versus 76% for controls, and exhibit impaired spermatogenesis, which might account for this decline in fecundity. Histological examination has revealed that, although many of the seminiferous tubules appear normal, about 20% do not possess a lumen and have little or no mature sperm cells. Additionally, the Leydig cells appear shrunken, suggesting that the lack of proper insulin signaling in the brain reduces the hormonal output necessary to retain the Leydig cell population for the successful promotion of spermatogenesis in all tubules. Moreover, a 60% reduction occurs in circulating LH, indicating that the lack of insulin response in the brain reduces hypothalamicpituitary axis function (Bruning et al. 2000) . Neither LH nor FSH has been measured in these animals, although the shrunken Leydig cells and low LH levels suggest a testosterone deficiency.
Other studies examining the mechanism of insulin signaling in the brain have found that insulin signaling in the brain is required for the inhibition of glucose production. Injection of insulin directly into the brain results in a decreased production of glucose independently of serum insulin levels. Injection of insulin signaling inhibitors cause increased glucose production, despite circulating serum insulin levels. This study further demonstrates that neuronal insulin action is regulated separately from plasma insulin and might be involved in overall energy homeostasis mediated by the central nervous system (Obici et al. 2002) .
Defects in the IRS signaling proteins can also have detrimental effects on fertility, since the IRS proteins are activated by the binding of insulin to its receptor. IRS-2 knockout males develop severe glucose intolerance and inadequate carbohydrate metabolism. Despite being initially fertile, IRS-2 knockout mice become infertile after the onset of diabetes . This suggests that the diabetic state, and not the lack of IRS-2, is responsible for the impairment in male reproductive capacity. Therefore, any number of hormones or glucose response pathways could be responsible for the subfertility in IRS-2 knockout males. IRS-2 protein might also mediate its effects through signaling to the brain. IRS-2 protein has been localized to the hypothalamus, together with the insulin receptor. Activation with insulin results in tyrosine phosphorylation of IRS-2 corresponding to the activation of PI3-kinase, indicating insulin signaling via the brain (Porte et al. 2005) .
Insulin levels are correlated to leptin levels Insulin's effects on the reproductive axis are not solely mediated by insulin interactions with receptors in the brain. Insulin levels are also known to be correlated directly to circulating levels of leptin, an important molecule involved in maintaining energy homeostasis. Leptin is a crucial hormone secreted by the fat cells that signals to the hypothalamus, and regulates the reproductive system. It serves as a metabolic signal that informs the brain of nutritional status and provides information regarding an animal's ability to meet the energy demands of reproduction (Barash et al. 1996) .
Type 1 diabetic males have decreased leptin levels, correlating to HPG axis dysfunction In type 1 diabetes, the decreased insulin levels can also affect leptin levels. Insulin has been shown in vitro to have direct effects on leptin synthesis (Barr et al. 1997; Cammisotto and Bukowiecki 2002; Wabitsch et al. 1996) . In fat cells, the administration of insulin promotes an increase in leptin production in vitro. In vivo, long-term exposure to hyperinsulinemia was shown to promote an increase in circulating leptin levels (Kolaczynski et al. 1996) . However, this effect was not seen instantaneously, but only in the final 24 h of the study, suggesting that the hypothalamic leptin response to insulin is an indirect mechanism acting through adipose cells. In humans, leptin levels are also affected by type 1 diabetes. Leptin levels are decreased in newly diagnosed type 1 diabetic patients before the administration of insulin treatment, but these levels normalize after the onset of insulin treatment (Azar et al. 2002) . Another study of newly diagnosed children with type 1 diabetes has demonstrated that leptin levels are low prior to insulin treatment and become elevated after only one day of insulin therapy. This leads to the conclusion that serum leptin is not simply a readout of body fat stores, but that it is also regulated by insulin levels (Hanaki et al. 1999) .
Further studies have established that both insulin and leptin potentiate insulin signaling in the brain. Injections of either insulin or leptin into the intracerebroventricular region of the brain elicit overlapping but distinct signaling mechanisms. Both hormones are able to affect the IRS and PI3-kinase signaling pathways, whereas insulin alone results in the phosphorylation of AKT serine (Carvalheira et al. 2005 ).
Uncontrolled type 1 diabetes is associated with decreased leptin levels Leptin clearly seems to play an important role in the development of type 1 diabetes. Decreased levels of leptin are associated with insulin resistance and other markers of metabolic syndrome, suggesting an interplay between the two molecules (German et al. 2010) . Additionally, decreased leptin levels in streptozocin-induced diabetic Wistar rats contribute to insulin resistance and metabolic syndrome prior to the development of hyperglycemia (German et al. 2010) . Another study has shown that leptin therapy alone in a nonobese diabetic mouse restores normal blood glucose levels and reverses the catabolic state of mice (Wang et al. 2010) . These data suggest that leptin effects lie downstream of insulin effects on metabolism, and thus that the restoration of leptin levels in type 1 diabetic males might reverse many of the effects insulin deficiency.
Disturbances in leptin signaling cause subfertility Through interactions with the hypothalamus, leptin signaling regulates fertility. Both the ob/ob and the db/db mouse models, which lack the leptin protein and the leptin receptor protein, respectively, exemplify the central role of leptin in the HPG axis. Both the ob/ob mouse and the db/db mouse have impaired fertility, and this defect is rescued by the administration of exogenous leptin. However, the defect in fertility is not restored with food restriction, suggesting that the lack of leptin, and not obesity, is responsible for this infertility (Mounzih et al. 1997) . Ob/ob males without leptin treatment have smaller testes, reduced numbers of sperm within the seminiferous tubules, and shrunken Leydig cells indicative of impaired steroidogenesis (Fujikawa et al. 2010) . Another study has found that free testosterone levels are not altered in the leptin-deficient ob/ob mice (Bhat et al. 2006) ; the authors speculate that this might be because the leptin-deficient mouse produces a binding protein that lowers free biologically active testosterone.
Leptin might mediate its effects by direct interactions with the hypothalamus. Leptin receptors are found in the rat and mouse brain, notably in the hypothalamus and in the pituitary, indicating a potential for leptin regulation at both sites. Injections of leptin directly into the rat hypothalamus stimulate the release of GnRH, suggesting that leptin directly acts within the hypothalamus to stimulate GnRH secretion in vivo (Watanobe 2002) . A study by Quennell et al. (2009) has found that leptin indirectly regulates the GnRH neurons. The authors deleted the leptin receptor either in the forebrain or in the GnRH neurons. Male infertility resulted only from deletion in the forebrain, suggesting an indirect mechanistic relationship between leptin and GnRH pulses. These experiments highlight the importance of leptin signaling to the brain for normal reproductive function.
Leptin receptors are also expressed in the testes, suggesting that leptin secreted by fat cells can directly signal to the gonads (Zamorano et al. 1997) . The expression of leptin receptor in the testes seems to be stage-specific, indicating a role in spermatogenesis. Expression is restricted to spermatocyes in stage IX and X of the testes, corresponding to the time just after sperm release (El-Hefnawy et al. 2000) ; the authors postulate that mature sperm suppress leptin receptor expression through a negative feedback loop that prevents the expression of the receptor in the other spermatogenic stages. Thus, disruptions in leptin production during the pathogenesis of diabetes might impact the gonadal axis at many levels: through signaling to the hypothalamus affecting GnRH pulses, through signaling to the pituitary affecting LH and FSH secretion, and through direct interactions with developing sperm cells in the testes.
Fertility effects of deficiency in the HPG axis
GnRH signaling from the hypothalamus is impaired in type 1 diabetic males Both leptin and insulin are known to interact with the hypothalamus ultimately to regulate the output of GnRH from the hypothalamus. These GnRH pulses subsequently affect hormones important in spermatogenesis, notably LH and FSH. The latter acts on the Sertoli cells of the testes to stimulate germ cell progression through mitosis and entry into meiosis (O'Shaughnessy et al. 2010; Selice et al. 2011 ). LH acts on the Leydig cells of the testes to stimulate testosterone synthesis (Amory and Bremner 2003) . Disruption of the HPG axis at any point in this hormonal loop results in a disruption of spermatogenesis.
A study in humans by Baccetti et al. (2002) has attempted to examine the function of the HPG axis in diabetic men by measuring LH and FSH secretion in response to GnRH and by transmission electron microscopy of sperm cells to look for abnormalities. The authors found that LH secretion in response to GnRH pulses was lower in diabetic men than in healthy controls (48±8 mIU/ml versus 59±10 mIU/ml; P<0.05). Upon examination of sperm ultrastructure, sperm from diabetic patients had a greater percentage of abnormally shaped acrosomes (Baccetti et al. 2002) . Another group found that impotent diabetic males had a lower LH response to GnRH pulses (Zeidler et al. 1982) . LH secretion in response to GnRH administration was also shown to be impaired in type 1 diabetic men in a study conducted by López-Alvarenga et al. (2002) . This study examined young diabetic men with no systemic complications of diabetes for an average of 3.7 years. The authors found that patients with poorly controlled diabetes had lower endogenous LH pulses and a decreased LH response to pulsatile GnRH administration. The authors concluded that the lack of LH response stemmed from the acute effects of diabetes, including hypoinsulinemia and hyperglycemia, and not from long-term systemic complications of the disease. These data taken together suggest that the pathogenesis of type 1 diabetes affects the hypothalamic pituitary axis resulting in decreased LH secretion. The low LH response might have negative implications on steroidogenesis in the Leydig cells, resulting in impaired spermatogenesis.
Disruptions in FSH signaling impair spermatogenesis
Disturbances in the HPG axis impact both LH and FSH levels, thereby impairing spermatogenesis. Scientists have attempted to isolate the roles of these hormones by developing mouse models lacking either FSH or its receptor. Mice lacking the FSH receptor (FORKO mice) have underdeveloped testes and a 50% reduction in the number of Sertoli cells . FORKO mice also show a decreased seminiferous tubule diameter and reduced sperm count corresponding to low testosterone levels (Krishnamurthy et al. 2000) . This mouse model further displays a delay in puberty, suggesting that FSH signaling is important in the onset of spermatogenesis . These mice remain fertile, however, suggesting that FSH is required for normal spermatogenesis but is not critical for fertility. In humans, mutations in FSH or its receptor are associated with fertility abnormalities. Three males with FSH-beta mutations have been described, all exhibiting subfertility including symptoms of small testes and azoospermia. Mutations in the FSH receptor result in low sperm counts or low sperm volume, but none of these patients are infertile (Meduri et al. 2008 ).
Disturbances in LH signaling impair late stages of spermatogenesis LH is necessary for spermatogenesis to occur properly. A study in men who were gonadotropin-deficient found that LH replacement restored spermatogenesis (Matsumoto et al. 1984) . In this same study, after azoospermia was achieved via exogenous testosterone administration, treatment with LH resulted in a significant increase in sperm concentration, although not to normal levels.
Mouse models of gonadotropin deficiency have provided greater insight into the importance and function of LH in spermatogenesis. Two different groups have made an LH receptor knockout mouse model (Lei et al. 2001; Zhang et al. 2001) . Both groups have found that LH-receptor null mice have reduced numbers of Leydig cells, and that spermatogenesis is arrested at the round spermatid stage. Testosterone replacement therapy in these mice results in the completion of spermatogenesis, although the Leydig cell population remains low in number and size. Mice treated with testosterone beginning at 30 days of age remain infertile (Lei et al. 2001) ; however, when mice are treated with high doses of testosterone, beginning at 21 days of age, partial fertility is restored (seven out of 78 matings, Pakarainen et al. 2005 ). This suggests that FSH alone is able to support the Sertoli cell population and the early stages of spermatogenesis, but that LH is required for the progression and/or maintenance of a mature sperm cell population.
Similar findings have been demonstrated in mice lacking the LH-beta-subunit. These mice are completely infertile, with reduced testis size and reduced or absent amounts of the hormones involved in the biosynthesis of testosterone. Additionally, the seminiferous tubules of these mice contain spermatogonia, spermatocytes, and round spermatids, but they lack any elongated and late-stage spermatids (Ma et al. 2004) . Both human and mouse data suggest that LH is critical to the completion of normal spermatogenesis through the stimulation of Leydig cell steroidogenesis.
Testosterone levels are decreased in uncontrolled type 1 diabetic males Several studies have evaluated the production of testosterone in diabetic men. Maneesh et al. (2006) have found that men with diabetes have reduced testosterone levels compared with age-matched control males, whereas LH and FSH levels remain similar. An investigation by van Dam et al. (2003) has shown that free testosterone levels are decreased, whereas total testosterone levels are similar in type 1 diabetic men versus control males. The authors have also demonstrated that LH levels are not different, whereas FSH levels are slightly increased (van Dam et al. 2003) . A study of newly diagnosed type 1 diabetic patients has revealed that plasma testosterone concentrations are decreased in diabetic patients but return to normal levels after 4 days of insulin treatment (Gluud et al. 1982) . Similarly, in type 1 diabetic patients whose androgen levels were measured before and after insulin withdrawal, testosterone levels were similar before insulin withdrawal but decreased below control levels significantly after 4 h of insulin withdrawal and remained lower throughout the 12-h study (Madsbad et al. 1986 ). Together, these data suggest that testosterone levels are impaired by type 1 diabetes in poorly controlled subjects, which could inhibit the process of spermatogenesis.
Diabetes is associated with poor sperm quality
The spermatogenic defects associated with diabetic males result, at least in part, from the known perturbations in the HPG axis. The characterization of these spermatogenic defects is an area of active research, as new technology for assaying the quality of sperm cells continues to be developed. Researchers have found that men with diabetes have sperm with significantly higher amounts of DNA damage ). Additionally, sperm from diabetic men have been shown to have greater DNA fragmentation and an increase in RAGE, a receptor protein important in the oxidative stress response (Karimi et al. 2011; Mallidis et al. 2007) . Moreover, sperm from type 1 diabetic men have an increased number of mitochondrial DNA deletions and an increase in sperm nuclear DNA fragmentation . Sperm from diabetic men and decreased embryo quality are also correlated. In vitro fertilization with sperm from diabetic men produces far fewer pregnancies compared with controls. However, two-cell embryo fertilization rates from using sperm from diabetic men are not impaired (Mulholland et al. 2011) . This indicates that the sperm cells are able to fertilize eggs and produce embryos, but that DNA damage prevents competent embryo development. Furthermore, work on both streptozocin-induced and genetically diabetic Akita mice has demonstrated that the sperm from these mice produce fewer two-cell embryos and, of these two-cell embryos, fewer develop successfully to the blastocyst stage. This suggests that the severe diabetes in these type I models affects sperm competence, thereby impairing proper embryo development (Kim and Moley 2008) .
A study by Ballester et al. (2004) sought to establish the linkage between diabetes and fertility by examining a type 1 diabetic rat model for defects in testicular signaling. The authors treated male Wistar rats with a single dose of streptozocin (70 mg/kg) rendering them diabetic. After 3 months, many of the rats were infertile and had smaller testes and lower numbers of Leydig cells than controls. Additionally, the serum levels of LH, FSH, and testosterone were all decreased. The authors suggested an indirect mechanism between insulin and LH, as they did not find a significant correlation between serum insulin and LH levels. This study showed an important relationship between type 1 diabetes and pituitary hormone signaling to the testes, leading to infertility when disturbed.
Insulin might also act directly in the testes to regulate spermatogenesis In addition to disturbances in the HPG axis, recent data have demonstrated the potential for local hormonal signaling within the testes. Identification of insulin, leptin, adiponectin, and resistin, in particular, provide a possible framework for regulation.
Aside from its effect on the HPG axis, insulin might also have a direct role in the testes and during spermatogenesis. Recent research has identified insulin expression in both the testes and sperm (Gómez et al. 2009 ). Insulin mRNA and protein expression have been detected in human sperm cells, and these cells respond to increasing concentrations of glucose with an increasing secretion of insulin (Aquila et al. 2005) . Additionally, sperm cells release insulin upon capacitation, the process by which sperm acquire the ability to fertilize. This provides a potential mechanism by which insulin has an autocrine role in sperm cells, which could serve to mediate sperm maturation and/or fertilization events.
Moreover, insulin transcripts and protein have been detected in the testes, raising the possibility that insulin interacts directly with receptors in the testes to promote the process of spermatogenesis. The detection of insulin in control and diabetic rat testes had also been reported, with lower levels of insulin protein in diabetic testes (Gómez et al. 2009 ). Histological examination has localized insulin to spermatids and Leydig cells. Furthermore, the insulin receptor has been localized to the cytoplasmic droplets of elongating spermatids just prior to their release into the lumen (Gómez et al. 2009 ). Together, these studies demonstrate the importance of local insulin signaling within the testes, in addition to systemic effects, although its specific role has not yet been determined. A study of cultured cells derived from chicken testes has shown that the incubation of testicular cells with insulin increases proliferation, as demonstrated by the incorporation of 3H-thymidine into the cells. This indicates that insulin has a mitogenic effect in the testes (Bobes et al. 2001) . The presence of insulin and its receptor has implications for the pathogenesis of diabetes, as the hypoinsulinemia associated with type 1 diabetes might directly interfere with insulin signaling at the level of the testes.
Noteworthy, other signaling molecules in addition to insulin have recently been identified within the testes, including resistin and adiponectin. This leads to the possibility of a local signaling network that could potentially regulate testis function. Adiponectin, an adipocyte hormone important in glucose homeostasis, has been detected in rat testes and localized to the interstitial Leydig cells (Caminos et al. 2008) . In this same study, adiponectin has been shown to decrease testosterone secretion in testicular tissue, displaying an important role for adiponectin in the local regulation of spermatogensis.
Resistin is another adipocyte hormone recently identified in testis. It is a hormone involved in insulin sensitivity, and its levels increase in type 1 diabetic patients (Shalev et al. 2004) . This hormone has recently been identified in the Leydig cells, and, to a lesser degree, in the Sertoli cells of the testis (Nogueiras et al. 2004) . Within the testis, resistin has been shown to decrease in response to fasting and to central leptin administration. Additionally, testicular sections incubated with resistin increase their production of testosterone, demonstrating the potential role of resistin as a regulator of spermatogenesis.
Hormone levels probably affect spermatogenesis on many levels, both through the HPG axis and through local signaling within the testis, However, the direct involvement of these hormones on spermatogenesis within the testes is still not thoroughly defined. Although type 1 diabetes is known to affect serum hormone levels of adiponectin, leptin, resistin, and insulin, a clear connection between diabetes and these testicular hormone levels remains to be established.
Concluding remarks
Disruptions in the HPG axis have severe reproductive consequences. type 1 diabetes can impact many aspects of the functional axis, resulting in subfertility. Low insulin levels attributable to type 1 diabetes lead to decreased leptin levels, in turn leading to decreased GnRH secretion, and subsequent decreases in LH and FSH signaling to the testes. However, the diabetic outcomes on fertility are probably mediated not only through the HPG axis, but also by the detrimental effects of hyperglycemia and oxidative DNA damage to the testes and sperm cells. Additionally, the presence of insulin transcripts in testes and sperm raises the possibility that insulin signaling is important within the testes and plays a part in the diabetic pathogenesis of infertility. Further work in the field is necessary to establish the precise role of direct insulin signaling in the testes and sperm cells and to determine whether diabetes has an impact on this local signaling. Identification of the cell types in the testis responsible for insulin signaling should help to clarify the potential role of insulin in the gonads. Furthermore, an insulin or insulin receptor knockout specifically in the testis should allow the distinction between systemic insulin deficiency and testis-specific insulin deficiency.
